TOA EIYO LTD.
|TOA EIYO LTD. Patent applications|
|Patent application number||Title||Published|
|20140158571||PACKAGING STRUCTURE FOR PATCHES - A packaging structure (||06-12-2014|
|20130065896||FUSED IMIDAZOLE DERIVATIVE - Provided is a novel compound which shows an antagonistic effect against T-type calcium channels, and is useful as a pharmaceutical product.||03-14-2013|
|20110104241||PERCUTANEOUS ABSORPTION ENHANCER AND TRANSDERMAL PREPARATION USING THE SAME - Provided are a percutaneous absorption enhancer excellent in an enhancing effect on percutaneous absorption of a wide range of drugs and excellent in compatibility with an adhesive base, and a transdermal preparation using the percutaneous absorption enhancer. The percutaneous absorption enhancer includes a sulfosuccinate or a salt thereof and an alkyl glycoside or an alkyl thioglycoside.||05-05-2011|
|20100098747||PERCUTANEOUS ADMINISTRATION DEVICE OF BISOPROLOL - The present invention relates to a percutaneous administration device of bisoprolol, which includes a backing; and a pressure-sensitive adhesive layer containing bisoprolol, which is laminated on one surface of the backing, wherein the maximum value of a release rate of bisoprolol during a period of from immediately after the application on skin until a lapse of 24 hours is 30 μg/cm||04-22-2010|
|20090291126||ADHESIVE PHARMACEUTICAL PREPARATION CONTAINING BISOPROLOL - An adhesive pharmaceutical preparation which has a less irritation to the skin surface, keeps excellent stability of bisoprolol in the preparation, and allows continuous administration of a pharmacologically effective amount of bisoprolol into the living body, is provided. The adhesive preparation||11-26-2009|
|20090170895||S1P3 RECEPTOR ANTAGONIST - The present invention relates to a medicine, and more particularly to novel arylamidrazone derivatives having an antagonistic action against S1P||07-02-2009|
|20090169604||Adhesive Pharmaceutical Preparation Containing Bisoprolol - In the adhesive pharmaceutical preparation of the invention containing bisoprolol, a pressure-sensitive adhesive layer is laminated on one side of the backing. The pressure-sensitive adhesive layer contains a branched monoalcohol having from 12 to 28 carbon atoms, a free base of bisoprolol and a polyisobutylene pressure-sensitive adhesive. Accordingly, compatibility of the polyisobutylene pressure-sensitive adhesive with the free base of bisoprolol can be specifically increased. As a result, not only it becomes possible to increase blending amount of the free base of bisoprolol but also bleed of the free base of bisoprolol from the pressure-sensitive adhesive layer can be suppressed and, what is more, the pressure-sensitive adhesion characteristics sufficient from the practical point of view can be obtained.||07-02-2009|
|20090012114||Cyclohepta[B]Pyridine-3-Carbonylguanidine Derivative and Pharmaceutical Product Containing Same - The present invention relates to a medicine, particularly a medicine comprising a novel cyclohepta[b]pyridine-3-carbonylguanidine derivative having an inhibitory effect on an Na||01-08-2009|
Patent applications by TOA EIYO LTD.